Shyamala Navada, MD, MSCR, Associate Professor, Hematology and Medical Oncology, @MountSinaiNYC @IcahnMountSinai offers opinion on how the treatment of myelodysplastic syndromes (MDS) is changing, especially as a result of the clinical data presented at ASH 2019.
Treatment Landscape of MDS Evolving @MountSinaiNYC @IcahnMountSinai
